Liposome-encapsulated Daunorubicin-Cytarabine, Fludarabine Phosphate, Cytarabine, and Filgrastim in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Todd M Cooper
Children's Oncology Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
73 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Iwk Health Centre
Halifax, Nova Scotia, Canada
- Kingston Health Sciences Centre
Kingston, Ontario, Canada
- Centre Hospitalier Universitaire Sainte-Justine
Montreal, Quebec, Canada
- the Montreal Children'S Hospital of the Muhc
Montreal, Quebec, Canada
- Centre Hospitalier Universitaire de Quebec
Québec, Canada
- Children'S Hospital of Alabama
Birmingham, Alabama, United States
- Phoenix Childrens Hospital
Phoenix, Arizona, United States
- Arkansas Children'S Hospital
Little Rock, Arkansas, United States
- Kaiser Permanente Downey Medical Center
Downey, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Loma Linda University Medical Center
Loma Linda, California, United States
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Valley Children'S Hospital
Madera, California, United States
- Ucsf Benioff Children'S Hospital Oakland
Oakland, California, United States
- Children'S Hospital of Orange County
Orange, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Ucsf Medical Center-Mission Bay
San Francisco, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Connecticut Children'S Medical Center
Hartford, Connecticut, United States
- Alfred I Dupont Hospital for Children
Wilmington, Delaware, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- University of Florida Health Science Center - Gainesville
Gainesville, Florida, United States
- Nemours Children'S Clinic-Jacksonville
Jacksonville, Florida, United States
- Nemours Children'S Clinic - Pensacola
Pensacola, Florida, United States
- Johns Hopkins All Children'S Hospital
St. Petersburg, Florida, United States
- Children'S Healthcare of Atlanta - Egleston
Atlanta, Georgia, United States
- Lurie Children'S Hospital-Chicago
Chicago, Illinois, United States
- Ascension Saint Vincent Indianapolis Hospital
Indianapolis, Indiana, United States
- Riley Hospital for Children
Indianapolis, Indiana, United States
- University of Kentucky/markey Cancer Center
Lexington, Kentucky, United States
- Eastern Maine Medical Center
Bangor, Maine, United States
- Maine Children'S Cancer Program
Scarborough, Maine, United States
- Johns Hopkins University/sidney Kimmel Cancer Center
Baltimore, Maryland, United States
- Dana-Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital Cancer Center
Boston, Massachusetts, United States
- C S Mott Children'S Hospital
Ann Arbor, Michigan, United States
- Ascension Saint John Hospital
Detroit, Michigan, United States
- University of Minnesota/masonic Cancer Center
Minneapolis, Minnesota, United States
- Mayo Clinic in Rochester
Rochester, Minnesota, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 May 2016
- Primary completion
- 31 Dec 2018
- Completion
- 30 Jun 2023
- Last update posted
- 8 Sept 2023
- Registered enrollment
- 38
- Registry id
- NCT02642965
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.